KLS-13019
KLS-13019 is an orally active GPR55 receptor antagonist and a structural analogue of cannabidiol (CBD) . It can prevent and reverse chemotherapy-induced peripheral neuropathy (CIPN) in a dose-dependent manner in rats[1].
Product Specifications
CAS Number
1801243-39-9
UNSPSC
12352005
Target
GPR55
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/kls-13019.html
Smiles
CC([C@@H]1CCC(C)=C[C@H]1C2=C(C=C(C=C2O)CC3CN(C3)C(C)=O)O)=C
Molecular Formula
C22H29NO3
Molecular Weight
355.47
References & Citations
[1]Ippolito MJ, et al. KLS-13019, a novel structural analogue of cannabidiol (CBD) and GPR55receptor antagonist, Prevents and Reverses Chemotherapy-Induced Peripheral Neuropathy (CIPN) in Rats. J Pharmacol Exp Ther. 2024 Aug 22:JPET-AR-2024-002190.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
ARP56687_P050-Biotin 100 µL
PIN4 Antibody - N-terminal region : Biotin (ARP56687_P050-Biotin)
Sign In for Pricing
View Details MBS2074072-01 0.1 mL
Cy3-Linked Polyclonal Antibody to Lipophilin B, Prostatein Like (LIPB)
Sign In for Pricing
View Details MBS2074072-02 0.2 mL
Cy3-Linked Polyclonal Antibody to Lipophilin B, Prostatein Like (LIPB)
Sign In for Pricing
View Details MBS2074072-03 0.5 mL
Cy3-Linked Polyclonal Antibody to Lipophilin B, Prostatein Like (LIPB)
Sign In for Pricing
View Details